Organizing Pneumonia After Mycoplasma — Antibiotics Failed, Steroids Worked

A 48-year-old African American male non-smoker with obesity, hypertension, and uncontrolled type 2 diabetes presented with a two-week history of persistent dry cough, fever, and progressive shortness of breath. He had initially been treated with oral ciprofloxacin by a telemedicine provider with no improvement. When he presented to the emergency department, chest radiographs showed patchy alveolar disease in the right mid-lung and both lung bases consistent with community-acquired pneumonia. He was not hypoxic at that time and was discharged on azithromycin.

After four days without improvement, he returned and was admitted. Mycoplasma pneumoniae infection was confirmed by positive IgM titers. IV doxycycline was started and he was transitioned to oral therapy and discharged. When he presented a third time with low-grade fever (100°F), mild hypoxia (SpO2 91% on room air), diffuse rales, and apical rhonchi, the clinical picture had evolved into something that could not be explained by Mycoplasma alone.

During his third admission, despite treatment with multiple antibiotic regimens including doxycycline, levofloxacin, azithromycin, vancomycin, and cefepime, his oxygen requirement escalated to 9 liters. Chest CT and repeat chest X-rays showed persistent bilateral interstitial infiltrates with evolving bronchiectasis and peripheral scarring.

Figure 1

CT Chest — Bilateral Interstitial Infiltrates and Bronchiectasis

Bilateral interstitial infiltrates with cylindrical bronchiectasis representing the characteristic CT appearance of organizing pneumonia. The persistence of these findings despite multiple antibiotic courses — in a patient confirmed to have had Mycoplasma pneumoniae infection — was the key clinical trigger for considering post-infectious COP rather than ongoing active infection. The bronchiectasis here reflects the process of fibroproliferative repair in the small airways rather than established structural bronchiectasis from chronic disease.

When high-dose oral prednisone (60 mg) was started, his oxygen requirements improved — providing the first therapeutic signal pointing toward an inflammatory rather than infectious etiology. The pulmonology and infectious disease teams proceeded with video-assisted thoracoscopic surgery (VATS) to obtain a lung biopsy. Pathology confirmed diffuse organizing pneumonia with organizing fibrosis in the terminal airways, chronic inflammation, increased alveolar foamy macrophages, and focal bronchiolitis obliterans — meeting diagnostic criteria for COP. Given the Mycoplasma infection one month prior, the pathologist identified this as a likely precipitating cause.

Figure 2

CT Chest — Evolving Peripheral Fibrosis and Bronchiectasis

Follow-up CT demonstrating development of pulmonary fibrosis with peripheral bronchiectasis and scarring — findings that emerged over weeks of failed antibiotic therapy and represent the fibroproliferative stage of post-Mycoplasma organizing pneumonia. The peripheral (subpleural) predominance of these changes is characteristic of COP and distinguishes it from centrally-distributed infectious pneumonia. This imaging pattern ultimately prompted the decision to proceed with surgical biopsy, which confirmed the diagnosis.

The patient and his family were counseled that recovery would be lengthy, requiring home oxygen and prolonged high-dose corticosteroids. Over time his oxygen requirements decreased sufficiently to allow use of a portable oxygen tank, and he was discharged home with outpatient pulmonology follow-up.

Discussion

Post-Mycoplasma organizing pneumonia is rare enough that it rarely appears in initial differentials — yet it follows a recognizable pattern that clinicians should learn to identify. The key feature is the temporal sequence: documented Mycoplasma infection, followed by antibiotic-responsive but relapsing or non-resolving respiratory symptoms, followed by escalating oxygen requirements despite appropriate antibiotic therapy. Mycoplasma pneumoniae causes a disproportionate inflammatory response relative to its direct cytopathic effect, and this immune-mediated injury can trigger the fibroproliferative alveolar repair process that defines COP histologically. In this case, the Mycoplasma infection likely served as the inciting injury, with the subsequent COP representing the dysregulated healing response.

The diagnostic timeline in this case illustrates a common failing: multiple antibiotic regimens were tried sequentially, each providing a few days of apparent improvement followed by relapse. This "antibiotic cycling" pattern — where each new drug briefly seems effective before the patient deteriorates again — should trigger consideration of non-infectious ILD early, not after five separate antibiotic courses have failed. The classic teaching is that antibiotic failure in a patient with pneumonia-like presentation should prompt HRCT, and COP should be on the differential when CT shows peripheral consolidation or bilateral infiltrates that persist beyond two to three weeks. Bronchoscopy with BAL is a reasonable first step, but when BAL is non-diagnostic and the patient continues to deteriorate, surgical biopsy via VATS provides the definitive histologic answer and should not be delayed.

Corticosteroids are the cornerstone of COP therapy and typically produce dramatic, rapid improvement — often within days to weeks. The initial partial response to prednisone in this case was both diagnostically informative and therapeutically meaningful. Long-term steroid therapy (6 to 24 months of tapering) is typically required for Mycoplasma-associated organizing pneumonia, and relapses are common during or after tapering. Patients and families should be counseled about the prolonged recovery trajectory, the need for home oxygen, and the importance of close pulmonology follow-up to monitor for relapse and manage steroid complications.